These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity. von Geldern TW; Tasker AS; Sorensen BK; Winn M; Szczepankiewicz BG; Dixon DB; Chiou WJ; Wang L; Wessale JL; Adler A; Marsh KC; Nguyen B; Opgenorth TJ J Med Chem; 1999 Sep; 42(18):3668-78. PubMed ID: 10479298 [TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat. Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091 [TBL] [Abstract][Full Text] [Related]
15. Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist. Murugesan N; Gu Z; Spergel S; Young M; Chen P; Mathur A; Leith L; Hermsmeier M; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Koplowitz B; Humphreys WG; Chong S; Morrison RA; Webb ML; Moreland S; Trippodo N; Barrish JC J Med Chem; 2003 Jan; 46(1):125-37. PubMed ID: 12502366 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ET A receptor antagonist, on the lower urinary tract. Ukai M; Yuyama H; Fujimori A; Koakutsu A; Sanagi M; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K Eur J Pharmacol; 2008 Feb; 580(3):394-400. PubMed ID: 18078923 [TBL] [Abstract][Full Text] [Related]
17. Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein. Tykocki NR; Gariepy CE; Watts SW J Pharmacol Exp Ther; 2009 Jun; 329(3):875-81. PubMed ID: 19297422 [TBL] [Abstract][Full Text] [Related]